Biomarkers for monitoring renal damage from occupational chromium exposure
DOI:
https://doi.org/10.62305/biosana.v5i5.854Keywords:
occupational exposure; chromium; kidney damage; biomarkers; nephrotoxicityAbstract
A descriptive literature review was conducted, focusing on analyzing the effects of occupational chromium exposure on renal function in exposed workers. Scientific articles published from 2016 onward were collected from recognized databases such as PubMed, Scopus, SciELO, Redalyc, and Web of Science. The results indicate that the most studied glomerular biomarkers were serum creatinine and estimated glomerular filtration rate (eGFR). Proximal tubular biomarkers included β2-microglobulin, retinol-binding protein (RBP), α1-microglobulin, N-acetyl-β-D-glucosaminidase (NAG), and kidney injury molecule-1 (KIM-1). Distal and mixed tubular biomarkers included albuminuria, total urinary protein, and neutrophil gelatinase-associated lipocalin (NGAL). Studies in tannery workers in Bangladesh, India, Pakistan, and Ethiopia demonstrated significant elevations in urinary KIM-1 (>24 times reference levels), total protein, and urinary chromium (2.89 ± 4.23 μg/g creatinine vs. <0.12 μg/g in the general population). A significant correlation was found between airborne chromium levels (0.05–15 mg/m³), urinary chromium, and biomarkers of tubular damage. The occupational reference values established by the ACGIH for urinary hexavalent chromium are: an increase >9.9 μg/L between pre- and post-shift (daily exposure) and >24.9 μg/L at the end of the workweek (cumulative exposure). It was concluded that KIM-1, NAG, β2-microglobulin, and RBP are sensitive biomarkers for the early detection of proximal tubular damage caused by chromium. Albuminuria and serum creatinine detect more advanced damage. Occupational health surveillance programs need to be implemented that include periodic biological monitoring (urinary chromium) combined with biomarkers of renal effect (KIM-1, NAG) to prevent chronic nephropathy in workers exposed to chromium, especially in tanning industries.
Downloads
References
Tsuchiyama T, Levy S, Nakamura K, et al. Increased levels of renal damage biomarkers caused by excess exposure to trivalent chromium in workers in tanneries. Environ Res. 2020;188:109770.
Zhou R, Zhang Q, Xu Q, et al. Urinary KIM-1: a novel biomarker for evaluation of occupational exposure to lead. Sci Rep. 2016;6:38930.
Hessel PA, Equivalent VB, Ventura C, et al. HBM4EU chromates study - Overall results and recommendations for the biomonitoring of occupational exposure to hexavalent chromium. Environ Int. 2021;157:106809.
Wu J, Zhang Y, Liu D, et al. Threshold effect of urinary chromium on kidney function biomarkers among Chinese adults. Ecotoxicol Environ Saf. 2023;249:114384.
Casasnovas JA, Domingo-Relloso A, García-Barrera T, et al. Association of single and joint metals with albuminuria and estimated glomerular filtration rate longitudinal change in middle-aged adults from Spain: The Aragon Workers Health Study. Environ Int. 2023;173:107838.
Kozłowska L, Woźniak B, Jośko-Ochojska J, et al. HBM4EU Chromates Study: Urinary metabolomics study of workers exposed to hexavalent chromium. Toxicol Lett. 2022;359:93-103.
Ruangyuttikarn W, Panyamoon A, Nambunmee K, et al. Use of the kidney injury molecule-1 as a biomarker for early detection of renal tubular dysfunction in a population chronically exposed to cadmium in the environment. SpringerPlus. 2013;2:533.
Amatruda JG, Avila-Palencia I, Metzger J, et al. Urine alpha-1-microglobulin levels and acute kidney injury, chronic kidney disease, cardiovascular events and mortality after cardiac surgery. Ann Intensive Care. 2021;11(1):131.
Saber AT, Lamson J, Jacobsen NR, et al. The SAM-Krom biomonitoring study shows occupational exposure to hexavalent chromium and increased genotoxicity in Denmark. Mutagenesis. 2025;40(1):12-23.
Verdonck J, Gerofke A, Yusa V, et al. Systematic review of biomonitoring data on occupational exposure to hexavalent chromium. Ann Work Expo Health. 2021;65(9):983-1004.
Jagannati M, Kabi S, Kumar R, et al. Occupation-related chromium toxicity: a rare cause of renal failure and rhabdomyolysis. Saudi J Kidney Dis Transpl. 2016;27(5):1026-1029.
Pócsi I, Dockrell ME, Price RG. Nephrotoxic biomarkers with specific indications for metallic pollutants: Implications for environmental health. Biomarkers. 2022;27(1):17-36.
Grau-Perez M, Navas-Acien A, Galan-Chilet I, et al. Association of single and joint metals with albuminuria and eGFR change: The Aragon Workers Health Study. Environ Res. 2023;216(Pt 3):114632.
van Meer L, Moerland M, van Dongen M, et al. Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. Br J Clin Pharmacol. 2014;77(6):947-957.
He Y, Huang C, Sun S, et al. Predictive value of cystatin C and neutrophil gelatinase-associated lipocalin for contrast-induced nephropathy: A meta-analysis. PLoS One. 2020;15(4):e0231174.
Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015;4(1):57-73.
Adverse Human Health Effects of Chromium by Exposure Route: A Comprehensive Review Based on Toxicogenomic Approach. Toxics. 2023;11(2):89.
Lindberg E, Vesterberg O. Monitoring exposure to chromic acid in chromeplating by measuring chromium in urine. Scand J Work Environ Health. 1983;9(4):333-340.
ACGIH. 2024 TLVs and BEIs: Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. American Conference of Governmental Industrial Hygienists; 2024.
Noncarcinogenic Effects of Chromium: Update to Health Assessment Document. EPA. 2024.
Chromium Toxicity - StatPearls - NCBI Bookshelf. Updated 2024.
ACGIH. Chromium and inorganic compounds. Documentation of BEIs. 2022.
OSHA. Occupational Exposure to Hexavalent Chromium. Final Rule. Federal Register. 2006;71(39):10099-10385.
NIOSH. NIOSH Criteria for a Recommended Standard: Occupational Exposure to Hexavalent Chromium. DHHS (NIOSH) Publication No. 2013-128; 2013.
ACGIH. Biological Exposure Indices (BEI) Introduction. 2024.
Occupational Exposure Assessment of Chromium (VI). Iran J Occup Health. 2017;14(4):11-24.
European Union. Directive (EU) 2017/2398 of the European Parliament and of the Council amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work. Off J Eur Union. 2017;L345:87-95.
Zamora FJV, Pérez SCM, Carrera BEL, González XNV. La Enfermedad de Chagas, un Problema de Salud: Situación en Ecuador. Revista Multidisciplinar de Estudios Generales. 2025;4(3):150-62.
HBM4EU Chromates Study: Determinants of Exposure to Hexavalent Chromium in Plating, Welding and Other Occupational Settings. Int J Environ Res Public Health. 2022;19(5):2975.
A Comprehensive Guide to Hexavalent Chromium. Workplace Hygiene. 2023.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749.
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
Exploring Renal Function Assessment: Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate Focused on the European Kidney Function Consortium Equation. Diagnostics. 2023;13(21):3328.
Markers of renal function tests. J Nephropharmacol. 2010;3(2):57-61.
Established and emerging markers of kidney function. Clin Chim Acta. 2012;413(17-18):1562-1568.
Validation of eGFR for Detecting Associations Between Serum Protein Biomarkers and Subsequent GFR Decline. Kidney Int Rep. 2023;8(4):814-824.
Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. Nephrol Dial Transplant. 2019;34(8):1306-1314.
Panel estimated Glomerular Filtration Rate (GFR): Statistical considerations for maximizing accuracy in diverse clinical populations. PLoS One. 2024;19(12):e0313862.
Consistency of metabolite associations with measured glomerular filtration rate in children and adults. Kidney Int. 2024;105(4):871-883.
Longitudinal NGAL and cystatin C plasma profiles present complementary information in cardiac surgery-associated acute kidney injury. Sci Rep. 2024;14(1):2321.
Novel Biomarkers of Kidney Function: Introduction and Overview. Medscape. 2023.
Value of Serum NGAL Combined with Serum Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy. Egypt J Hosp Med. 2022;89(1):4663-4669.
A Comprehensive Review of Advanced Biomarkers for Early Detection and Management of Chronic Kidney Disease in Older Adults. Cureus. 2024;16(5):e60012.
Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237-244.
Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010;28(5):436-440.
Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008;245(3):182-193.
Endre ZH, Pickering JW, Walker RJ. Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am J Physiol Renal Physiol. 2011;301(4):F697-F707.
Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73(9):1008-1016.
Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med. 2010;4(2):265-280.
Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015;4(1):57-73.
Early-effect biomarkers and hazard index approaches to chromium exposure assessment. ScienceDirect. 2018.
Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008-2020. Environ Res. 2021;204:112279.
Threshold effect of urinary chromium on kidney function in a general population. ScienceDirect. 2023.
Lipid peroxidation due to tri-valent chromium exposure among tannery workers. Egypt J Occup Med. 2007;31(2):239-254.
Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta. 2004;346(2):107-118.
Urine Alpha-1-Microglobulin Levels and Acute Kidney Injury, Chronic Kidney Disease, Cardiovascular Events and Mortality After Cardiac Surgery. Ann Intensive Care. 2021;11(1):131.
Urine alpha1-microglobulin is a better marker for early tubular damage in critically ill children. Braz J Infect Dis. 2015;19(3):256-261.
Chromium Status of Tannery Workers in Relation to Metabolic Disorders. J Appl Toxicol. 1999;19(6):437-446.
Alpha-1-microglobulin profile in patients on maintenance hemodialysis. Sci Rep. 2025;15(1):10943.
Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery. Lancet. 2024;403(10430):939-949.
Recombinant alpha-1 microglobulin to improve outcomes in kidney transplantation and critically ill patients. Clin Kidney J. 2025;18(9):sfae261.
Saner G, et al. Retinol-binding protein in workers exposed to chromium compounds. Toxicol Lett. 1984;21(2):165-168.
Chromium Contamination in Tannery Effluent. PHAROS. 2023.
Impacts of Chromium from Tannery Effluent and Evaluation of Alternative Treatment Options. J Environ Prot. 2010;1(1):53-58.
Association of Single and Joint Metals with Albuminuria and eGFR Change. CDC NIOSH. 2023.
Chromium removal potential from tannery process by native microorganisms: A review. Heliyon. 2024;10(3):e25285.
Recovery of Total Chromium from Tannery Wastewater by Chemical Precipitation. Case Stud Chem Environ Eng. 2023;7:100310.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 BIOSANA Health Scientific Journal. ISSN 2960-8481

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




